Obeticholic acid, a ligand for the Farnesoid X nuclear receptor, was found to improve the histological features of NASH in a multicentre, randomized, placebo‐controlled trial.18 The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.